Rockwell Medical, Inc. (RMTI) — 8-K Filings

8-K Filings (15)

• 8-K Filing — May 7, 2026
• Rockwell Medical Files 8-K with Investor Presentation — Mar 26, 2026
  Rockwell Medical, Inc. filed an 8-K on March 26, 2026, under Item 7.01, Regulation FD Disclosure, indicating they are publicly sharing information that was not
• Rockwell Medical Files 8-K on Q4/FY Earnings — Mar 26, 2026
  Rockwell Medical, Inc. filed an 8-K on March 26, 2026, to report its latest financial results, specifically under Item 2.02, "Results of Operations and Financia
• Rockwell Medical Announces Executive and Board Changes — Nov 18, 2025 Risk: medium
  On November 17, 2025, Rockwell Medical, Inc. announced changes in its executive team and board of directors. The filing details the departure of certain officer
• Rockwell Medical Announces Executive and Board Changes — Sep 29, 2025 Risk: medium
  On September 23, 2025, Rockwell Medical, Inc. announced changes in its executive team and board of directors. The company appointed Dr. Robert L. Johnson as Chi
• Rockwell Medical Files 8-K for Security Holder Vote — May 20, 2025 Risk: low
  On May 20, 2025, Rockwell Medical, Inc. filed an 8-K report to announce the submission of matters to a vote of its security holders. The filing does not disclos
• Rockwell Medical, Inc. Files 8-K on Financials — May 12, 2025 Risk: low
  On May 12, 2025, Rockwell Medical, Inc. filed an 8-K report detailing its financial results and operations. The filing provides updates on the company's financi
• Rockwell Medical Files 8-K with Financial Updates — Mar 20, 2025 Risk: low
  On March 20, 2025, Rockwell Medical, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhib
• Rockwell Medical Appoints New CMO, Elects Directors — Dec 12, 2024 Risk: medium
  Rockwell Medical, Inc. announced on December 10, 2024, the appointment of Dr. Robert L. Judd as Chief Medical Officer and the election of Ms. Karen L. King and
• Rockwell Medical Files 8-K: Other Events & Financials — Nov 13, 2024 Risk: low
  On November 13, 2024, Rockwell Medical, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicati
• Rockwell Medical Enters Material Definitive Agreement — Jul 15, 2024 Risk: medium
  On July 12, 2024, Rockwell Medical, Inc. entered into a Material Definitive Agreement, the specifics of which are detailed in the filing. The company, incorpora
• Rockwell Medical Holds Shareholder Vote — May 23, 2024 Risk: low
  On May 21, 2024, Rockwell Medical, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders. The filing indicates a meeting or v
• Rockwell Medical Files 8-K on Financials — Mar 21, 2024 Risk: low
  On March 21, 2024, Rockwell Medical, Inc. filed an 8-K report detailing its financial results and condition. The filing includes financial statements and exhibi
• Rockwell Medical Confirms Nasdaq Capital Market Listing — Jan 9, 2024
  Rockwell Medical, Inc. filed an 8-K on January 8, 2024, to disclose that its common stock, with a par value of $0.0001, is registered on the Nasdaq Capital Mark
• Rockwell Medical Raises $1M via Private Placement, Issues Warrants — Jan 8, 2024
  On January 2, 2024, Rockwell Medical, Inc. entered into a definitive agreement with an institutional investor for a private placement of 1,000,000 shares of its

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX